Free Trial

Bexil Q2 2024 Earnings Report

$40.00 0.00 (0.00%)
(As of 12/20/2024 ET)

Bexil EPS Results

Actual EPS
-$0.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bexil Revenue Results

Actual Revenue
$0.70 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bexil Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

Bexil Earnings Headlines

No headlines for this company have been tracked by MarketBeat.com
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bexil? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bexil and other key companies, straight to your email.

About Bexil

Bexil (OTCMKTS:BXLC), through its subsidiaries, engages in the investment management and securities trading activities in the United States. The company was incorporated in 1996 and is based in Rochester, New York.

View Bexil Profile

More Earnings Resources from MarketBeat

Upcoming Earnings